Spots Global Cancer Trial Database for stage iv nsclc
Every month we try and update this database with for stage iv nsclc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 2 Study of Dacomitinib in NSCLC | NCT04027647 | NSCLC Stage III... NSCLC Stage III... NSCLC Stage IV Recurrent NSCLC EGFR Positive N... | Dacomitinib | 18 Years - | National Cancer Centre, Singapore | |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | NCT04614103 | Metastatic Non ... | LN-145 LN-145 | 18 Years - 70 Years | Iovance Biotherapeutics, Inc. | |
| ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer | NCT00328562 | Non-Small Cell ... | ZD1839 (Iressa) Thoracic Radiot... | 18 Years - | Thomas Jefferson University | |
| Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer | NCT01640730 | Stage IV NSCLC | Kanglaite Injec... | 18 Years - | KangLaiTe USA | |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | NCT05361174 | Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm... | IOV-4001 | 18 Years - | Iovance Biotherapeutics, Inc. | |
| Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients | NCT03812549 | Stage IV NSCLC | Sintilimab stereotactic bo... Low Dose Radiot... | 18 Years - 70 Years | Sichuan University | |
| Combination of Metformin With Gefitinib to Treat NSCLC | NCT01864681 | NSCLC EGFR Gene Ampli... Advanced Cancer Stage IIIB NSCL... Stage IV NSCLC | Gefitinib and M... Gefitinib and p... | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | NCT00413283 | Lung Cancer Chemotherapy-In... Non-Small Cell ... Cancer Lung Neoplasms Oncology Solid Tumors Thrombocytopeni... | Romiplostim Placebo Gemcitabine Carboplatin Cisplatin | 18 Years - | Amgen | |
| Combination of Metformin With Gefitinib to Treat NSCLC | NCT01864681 | NSCLC EGFR Gene Ampli... Advanced Cancer Stage IIIB NSCL... Stage IV NSCLC | Gefitinib and M... Gefitinib and p... | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer | NCT03915951 | Non-small Cell ... | encorafenib binimetinib | 18 Years - | Pfizer | |
| Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib | NCT05988697 | NSCLC BRAF V600E Muta... Advanced Cancer Stage IIIB NSCL... Stage IV NSCLC | Combind asprin ... | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients | NCT03812549 | Stage IV NSCLC | Sintilimab stereotactic bo... Low Dose Radiot... | 18 Years - 70 Years | Sichuan University | |
| An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer | NCT03915951 | Non-small Cell ... | encorafenib binimetinib | 18 Years - | Pfizer | |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | NCT00413283 | Lung Cancer Chemotherapy-In... Non-Small Cell ... Cancer Lung Neoplasms Oncology Solid Tumors Thrombocytopeni... | Romiplostim Placebo Gemcitabine Carboplatin Cisplatin | 18 Years - | Amgen | |
| Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer | NCT01438307 | Non-small Cell ... Stage IV NSCLC Metastatic NSCL... | Cabazitaxel-XRP... Cabazitaxel-XRP... | 19 Years - | University of Alabama at Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
